Infleqtion | $100,000,000 | (Jun 3, 2025)
Moments Lab | $24,000,000 | (Jun 3, 2025)
LuminX | $5,500,000 | (Jun 3, 2025)
Certified by Founder
Lodge
Carmot Therapeutics, Inc.
start up
United States
- Berkeley
- 26/07/2022
- Series D
- $160,000,000
Carmot Therapeutics, Inc. is a clinical-stage company dedicated to the discovery and development of innovative medicines. Carmot applies a transformative, patented drug discovery approach, Chemotype Evolution to explore novel frontiers of chemistry and biology. Using Chemotype Evolution, Carmot has developed a portfolio of drug candidates in metabolic disease and oncology.
- Industry Biotechnology Research
- Website https://carmot-therapeutics.us/contact-us/
- LinkedIn https://www.linkedin.com/company/carmot-therapeutics-inc/
Archil | $6,700,000 | (Jun 3, 2025)
Limited | $7,000,000 | (Jun 3, 2025)
Dexari | $2,300,000 | (Jun 3, 2025)
Heron Power | $38,000,000 | (Jun 3, 2025)
Trustifi | $25,000,000 | (Jun 3, 2025)
Literal Labs | $6,223,938 | (Jun 3, 2025)
Volteras | $11,100,000 | (May 30, 2025)
ROXFIT | $1,077,281 | (May 30, 2025)
Dream Park Immersive | $1,100,000 | (May 30, 2025)